NVCR icon

NovoCure

314 hedge funds and large institutions have $5.64B invested in NovoCure in 2022 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 90 increasing their positions, 107 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

16% less repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 107

17% less capital invested

Capital invested by funds: $6.79B → $5.64B (-$1.16B)

18% less call options, than puts

Call options by funds: $69.3M | Put options by funds: $84.2M

Holders
314
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$69.3M
Puts
$84.2M
Net Calls
Net Calls Change

Top Buyers

1 +$126M
2 +$41.7M
3 +$23.7M
4
Morgan Stanley
Morgan Stanley
New York
+$20.8M
5
Jane Street
Jane Street
New York
+$17.9M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$1.61M
102
$1.61M
103
$1.6M
104
$1.52M
105
$1.5M
106
$1.48M
107
$1.45M
108
$1.43M
109
$1.39M
110
$1.35M
111
$1.29M
112
$1.28M
113
$1.28M
114
$1.27M
115
$1.24M
116
$1.22M
117
$1.21M
118
$1.18M
119
$1.1M
120
$1.09M
121
$1.08M
122
$1.05M
123
$997K
124
$968K
125
$943K